Data management of clinical trials during an outbreak of Ebola virus disease

被引:2
|
作者
Hossmann, Stefanie [1 ]
Haynes, Alan G. [1 ]
Spoerri, Adrian [2 ]
Diatta, Ibrahima Dina [1 ]
Aboubacar, Barry [3 ]
Egger, Matthias [2 ]
Rintelen, Felix [1 ]
Trelle, Sven [1 ,2 ]
机构
[1] Univ Bern, CTU Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland
[2] Univ Bern, ISPM, Finkenhubelweg 11, CH-3012 Bern, Switzerland
[3] WHO, Conakry, Guinea
关键词
Clinical trial; Data management; Data management centre; Electronic data capturing system; REDCap;
D O I
10.1016/j.vaccine.2017.09.094
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Clinical trial data management (DM) conducted during outbreaks like that of Ebola virus disease (EVD) in West Africa, 2014-2016, has to adapt to specific, unique circumstances. CTU Bern was asked to set up a safe data capture/management system that could be launched within a few weeks and cover two different vaccine trials. This article describes some of the challenges we faced and our solutions during the two different trials. Methods: Setting up a DM system was split into four phases/tasks: (1) quick set-up of the (electronic) data capture system (EDC) and mobile infrastructure in Bern, (2) moving the EDC and infrastructure to Conakry, Guinea and implementation of a local data management centre (DMC), (3) running the DMC, and (4) data cleaning. The DMC had to meet the following criteria: (1) quick implementation, (2) efficient maintenance and handling of data, and (3) procedures to guarantee data quality. The EDC (REDCap) was setup as a local area network. In order to ensure high data quality, double data entry, and then review of inconsistencies and offline plausibility checks were implemented. Results: From the start of CTU Bern's involvement to the productive EDC took 11 weeks. It was necessary to adapt processes for dealing with data continuously throughout the trial conduct phase. The data management team processed 171,794 case report form pages from a total of 14,203 participants in the period between March and December 2015. Conclusion: Data management is a key task supporting trial conduct. For trials in emergency situations, many of our approaches are suitable, but we also provide a list of aspects that might be done differently. (C) 2017 Published by Elsevier Ltd.
引用
收藏
页码:7183 / 7189
页数:7
相关论文
共 50 条
  • [31] Research misconduct and data fraud in clinical trials
    Viroj Wiwanitkit
    International Journal of Clinical Oncology, 2016, 21 : 1196 - 1196
  • [32] Research misconduct and data fraud in clinical trials
    Wiwanitkit, Viroj
    International Journal of Clinical Oncology, 2016, 21 (06) : 1196 - 1196
  • [33] Terminology for a FAIR Framework for the Virus Outbreak Data Network-Africa
    Plug, Ruduan
    Liang, Yan
    Aktau, Aliya
    Basajja, Mariam
    Oladipo, Francisca
    van Reisen, Mirjam
    DATA INTELLIGENCE, 2022, 4 (04) : 698 - 723
  • [34] CDISC-compliant clinical trial imaging management system with automatic verification and data Transformation: Focusing on tumor response assessment data in clinical trials
    Lee, Amy Junghyun
    Kim, Kyung Won
    Shin, Youngbin
    Lee, Jiwoo
    Park, Hyo Jung
    Cho, Young Chul
    Ko, Yousun
    Sung, Yu Sub
    Yoon, Byung Sun
    JOURNAL OF BIOMEDICAL INFORMATICS, 2021, 117
  • [35] Trends in Consent for Clinical Trials in Cardiovascular Disease
    Kerkhoff, Louis A.
    Butler, Javed
    Kelkar, Anita A.
    Shore, Supriya
    Speight, Candace D.
    Wall, Louisa K.
    Dickert, Neal W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [36] Experiences of perceived vs actual time required for data management on electronic data capture clinical trials in a non commercial setting
    Nancy Tappenden
    Lindsey Masters
    Trials, 14 (Suppl 1)
  • [37] LIMS and Clinical Data Management
    Chen, Yalan
    Lin, Yuxin
    Yuan, Xuye
    Shen, Bairong
    TRANSLATIONAL BIOMEDICAL INFORMATICS: A PRECISION MEDICINE PERSPECTIVE, 2016, 939 : 225 - 239
  • [38] The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSVΔG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak
    Samai, Mohamed
    Seward, Jane F.
    Goldstein, Susan T.
    Mahon, Barbara E.
    Lisk, Durodami Radcliffe
    Widdowson, Marc-Alain
    Jalloh, Mohamed I.
    Schrag, Stephanie J.
    Idriss, Ayesha
    Carter, Rosalind J.
    Dawson, Peter
    Kargbo, S. A. S.
    Leigh, Bailah
    Bawoh, Mohamed
    Legardy-Williams, Jennifer
    Deen, Gibrilla
    Carr, Wendy
    Callis, Amy
    Lindblad, Robert
    Russell, James B. W.
    Petrie, Carey R.
    Fombah, Augustin E.
    Kargbo, Brima
    McDonald, Wendi
    Jarrett, Olamide D.
    Walker, Robert E.
    Gargiullo, Paul
    Bash-Taqi, Donald
    Gibson, Laura
    Fofanah, Abu Bakarr
    Schuchat, Anne
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 : S6 - S15
  • [39] PCSK9 inhibitors in the management of atherosclerotic cardiovascular disease: Current clinical trials and future directions
    Nie, Wenyi
    Yue, Yingbin
    Hu, Jingqing
    ATHEROSCLEROSIS, 2024, 399
  • [40] The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection
    Davey, Richard T., Jr.
    Dodd, Lori
    Proschan, Michael
    Jahrling, Peter
    Hensley, Lisa
    Higgs, Elizabeth
    Lane, H. Clifford
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 : S690 - S697